Effects of pharmacological modulators of α-synuclein and tau aggregation and internalization
Open Access
- 30 July 2020
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 10 (1) , 1-18
Abstract
Parkinson's disease (PD) and Alzheimer's disease (AD) are common neurodegenerative disorders of the elderly and, therefore, affect a growing number of patients worldwide. Both diseases share, as a common hallmark, the accumulation of characteristic protein aggregates, known as Lewy bodies (LB) in PD, and neurofibrillary tangles in AD. LBs are primarily composed of misfolded α-synuclein (aSyn), and neurofibrillary tangles are primarily composed of tau protein. Importantly, upon pathological evaluation, most AD and PD/Lewy body dementia cases exhibit mixed pathology, with the co-occurrence of both LB and neurofibrillary tangles, among other protein inclusions. Recent studies suggest that both aSyn and tau pathology can spread and propagate through neuronal connections. Therefore, it is important to investigate the mechanisms underlying aggregation and propagation of these proteins for the development of novel therapeutic strategies. Here, we assessed the effects of different pharmacological interventions on the aggregation and internalization of tau and aSyn. We found that anle138b and fulvic acid decrease aSyn and tau aggregation, that epigallocatechin gallate decreases aSyn aggregation, and that dynasore reduces tau internalization. Establishing the effects of small molecules with different chemical properties on the aggregation and spreading of aSyn and tau will be important for the development of future therapeutic interventions.Keywords
All Related Versions
This publication has 89 references indexed in Scilit:
- Anle138b: a novel oligomer modulator for disease-modifying therapy of neurodegenerative diseases such as prion and Parkinson’s diseaseActa Neuropathologica, 2013
- Paired Helical Filaments from Alzheimer Disease Brain Induce Intracellular Accumulation of Tau Protein in AggresomesJournal of Biological Chemistry, 2012
- Dynamin, a membrane-remodelling GTPaseNature Reviews Molecular Cell Biology, 2012
- The role of clathrin in mitotic spindle organisationJournal of Cell Science, 2012
- The Dynamin Chemical Inhibitor Dynasore Impairs Cholesterol Trafficking and Sterol-Sensitive Genes Transcription in Human HeLa Cells and MacrophagesPLOS ONE, 2011
- The Flavanol (−)-Epigallocatechin 3-Gallate Inhibits Amyloid Formation by Islet Amyloid Polypeptide, Disaggregates Amyloid Fibrils, and Protects Cultured Cells against IAPP-Induced ToxicityBiochemistry, 2010
- Molecular mechanism of Thioflavin-T binding to amyloid fibrilsBiochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2010
- EGCG remodels mature α-synuclein and amyloid-β fibrils and reduces cellular toxicityProceedings of the National Academy of Sciences of the United States of America, 2010
- HPV16 and BPV1 Infection Can Be Blocked by the Dynamin Inhibitor DynasoreAmerican Journal of Therapeutics, 2008
- EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomersNature Structural & Molecular Biology, 2008